Comprehensive Management of Drug Prescriptions Throughout the Elderly Person’s Hospital Care

Overview

This study evaluates the impact of optimizing drug prescriptions on re-admissions of elderly patients within 30 days after hospital discharge. It compares a group of patients receiving comprehensive care (medication reconciliation at hospital entry, multidisciplinary medication review, and medication reconciliation at discharge), versus another group that does not benefit from the program.

Full Title of Study: “Comprehensive Management of Drug Prescriptions Throughout the Elderly Person’s Hospital Care, From Hospital to Home: Impact on Readmission at 30 Days After Delivery”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 17, 2018

Interventions

  • Other: global care
    • Medication Reconciliation at admission, Multidisciplinary medication review, Medication Reconciliation at discharge

Arms, Groups and Cohorts

  • No Intervention: Control
    • Standard healthcare procedures
  • Experimental: experimental: Reconciliation group
    • medical reconciliation at admission, multidisciplinary medication review, medical reconciliation at discharge of the hospital

Clinical Trial Outcome Measures

Primary Measures

  • Rate of readmission at 30 days
    • Time Frame: 30 days
    • Evaluate the impact of optimizing drug prescriptions on re-admissions of elderly patients within 30 days of return to home.Only direct re-admissions to emergency and geriatric short-stay services in participating centres will be counted.

Secondary Measures

  • Time between discharge and first readmission
    • Time Frame: 30 days
    • Evaluate the impact of medication management on the time required for the first re-admission to hospital, if it takes place before 30 days.
  • Rate of changes in the prescription after hospital discharge by the general practitioner
    • Time Frame: 30 days
    • Estimate the impact of this process on the preservation of the prescription after hospital discharge by general practitioner within the 30 days following the return home actual number of discrepancies, what may have caused the change and which are the concerned drugs
  • Identification of Seniors at Risk (ISAR) score
    • Time Frame: 30 days
    • This score is based on 6 yes/no questions. T e total scale range is from 0 to 6. Each item is scored 1 if there is a problem or 0 if there is not, being the maximum score =6.

Participating in This Clinical Trial

Inclusion Criteria

  • Patients hospitalized in the department of short geriatric stay Exclusion Criteria:

  • Patients already included in the study, and readmitted in the same service.

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Lille Catholic University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Fabien Visade, MD, Principal Investigator, GHICL

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.